| Indiana Medical Group | |
|
407 E Lincolnway Valparaiso IN 46383-5483 | |
| (888) 339-7339 | |
| Not Available |
| Full Name | Indiana Medical Group |
|---|---|
| Speciality | General Practice |
| Location | 407 E Lincolnway, Valparaiso, Indiana |
| Authorized Official Name and Position | Kinjot Singh (CEO - PRESIDENT) |
| Authorized Official Contact | 8883397339 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Indiana Medical Group 407 E Lincolnway Valparaiso IN 46383-5483 Ph: (888) 339-7339 | Indiana Medical Group 407 E Lincolnway Valparaiso IN 46383-5483 Ph: (888) 339-7339 |
| NPI Number | 1023321684 |
|---|---|
| Provider Enumeration Date | 07/23/2010 |
| Last Update Date | 07/23/2010 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023321684 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | (* (Not Available)) | Primary |
News Archive
According to the Centers for Disease Control and Prevention, cataracts are the number one cause of vision loss in the United States. Nearly 22 million Americans age 40 and over have cataracts, while more than half of individuals age 80 and over suffer from this condition. In a recent study released in JAMA Ophthalmology, it was confirmed that statins, which are typically prescribed to reduce cholesterol and also prevent heart disease, may cause an increased risk for cataracts among individuals ages 30 through 85.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the second quarter ended June 30, 2015, adjusted net income was $170 million compared to $157 million for 2014. Adjusted diluted EPS excluding amortization was $1.25 in the second quarter of 2015, compared to $1.19 in 2014. Amortization expense per diluted share was $0.08 in the second quarter of 2015 and $0.11 in 2014.
The U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee today voted 9 to 0 in favor of approving dabigatran etexilate for stroke prevention in patients with atrial fibrillation (AFib). An estimated 2.3 million Americans have AFib and the prevalence is expected to increase 2.5 fold to 5.6 million by 2050, reflecting the growing population of elderly individuals.
Health disparities have persisted, despite extensive research and a decades-long mandate to eliminate them. Thus, the National Institute on Minority Health and Health Disparities led a National Institutes of Health-wide, two-year science visioning process to chart a new research course to improve minority health and reduce health disparities.
› Verified 1 days ago
Healthlinc - Porter-starke Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 701 Wall St, Valparaiso, IN 46383 Phone: 219-299-8419 Fax: 219-462-7504 | |
New Beginnings Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 109 Fordwick Ln, Valparaiso, IN 46383 Phone: 219-671-1881 | |
B Waldo Md Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3000 Pepper Creek Bridge Pkwy, Valparaiso, IN 46385 Phone: 773-520-1950 | |
Sudhakar Garlapati Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 401 Wall St, Valparaiso, IN 46383 Phone: 219-462-2106 | |
Michigan City In Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2206 Roosevelt Rd, Ste A, Valparaiso, IN 46383 Phone: 219-464-9507 Fax: 219-477-4690 | |
James E. Taylor Medical Professional Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2102 Evans Ave, Suite 111, Valparaiso, IN 46383 Phone: 219-464-9521 |